Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluad vs VaxiGrip in Senegalese Children
NCT01819155Phase 2Completed
- Sponsor
- PATH
- Start
- Apr 2013
- Primary completion
- Sep 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Fluzone Trivalent in influenza, sponsored by PATH. Primary endpoint: Hemagglutination Inhibition Antibody Titer for adjTIV. Started Apr 2013; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01819155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01819155.